EUVIMEDEUVIMED entdecken
Crossref

Clinical Impact of Contouring Variability for Prostate Cancer Tumor Boost

Allison Y Zhong, Asona J Lui, Svetlana Kuznetsova, Karoline Kallis, Christopher Conlin, Deondre D Do, Mariluz Rojo Domingo, Ryan Manger, Patricia Hua, Roshan Karunamuni, Joshua Kuperman, Anders M Dale und 5 weitere

International Journal of Radiation Oncology*Biology*Physics · 2024

DOI: 10.1016/j.ijrobp.2024.06.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2024. Verfasst von Allison Y Zhong und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Medicine and Applied Sciences, UC San Diego School of Medicine, La Jolla, California. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Radiotherapy Planning, Computer-Assisted, Magnetic Resonance Imaging. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: RSNA, Congressionally Directed Medical Research Programs, National Institute of Biomedical Imaging and Bioengineering.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The focal radiation therapy (RT) boost technique was shown in a phase III randomized controlled trial (RCT) to improve prostate cancer outcomes without increasing toxicity. This technique relies on the accurate delineation of prostate tumors on MRI. A recent prospective study evaluated radiation oncologists' accuracy when asked to delineate prostate tumors on MRI and demonstrated high variability in tumor contours. We sought to evaluate the impact of contour variability and inaccuracy on predicted clinical outcomes. We hypothesized that radiation oncologists' contour inaccuracies would yield meaningfully worse clinical outcomes. METHODS AND MATERIALS: Forty-five radiation oncologists and 2 expert radiologists contoured prostate tumors on 30 patient cases. Of these cases, those with CT simulation or diagnostic CT available were selected for analysis. A knowledge-based planning model was developed to generate focal RT boost plans for each contour per the RCT protocol. The probability of biochemical failure (BF) was determined using a model from the RCT. The primary metric evaluated was delta BF (DBF = Participant BF - Expert BF). An absolute increase in BF ≥5% was considered clinically meaningful. RESULTS: Eight patient cases and 394 target volumes for focal RT boost planning were included in this analysis. In general, participant plans were associated with worse predicted clinical outcomes compared to the expert plan, with an average absolute increase in BF of 4.3%. Of participant plans, 37% were noted to have an absolute increase in BF of 5% or more. CONCLUSIONS: Radiation oncologists' attempts to contour tumor targets for focal RT boost are frequently inaccurate enough to yield meaningfully inferior clinical outcomes for patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsRadiotherapy Planning, Computer-AssistedMagnetic Resonance ImagingHumansMaleRadiation OncologistsTomography, X-Ray ComputedObserver VariationProspective StudiesTumor BurdenAged

Autor:innen und Institutionen

  • Department of Radiation Medicine and Applied Sciences, UC San Diego School of Medicine, La Jolla, California.
  • Department of Radiology, UC San Diego School of Medicine, La Jolla, California.
  • Department of Bioengineering, UC San Diego Jacobs School of Engineering, La Jolla, California.
  • Department of Radiology, UC San Diego School of Medicine, La Jolla, California; Department of Neurosciences, UC San Diego School of Medicine, La Jolla, California; Halıcıoğlu Data Science Institute, UC San Diego School…
  • Department of Radiology, UC San Diego School of Medicine, La Jolla, California; Department of Bioengineering, UC San Diego Jacobs School of Engineering, La Jolla, California.
  • Department of Radiation Oncology, The Netherlands Cancer Institute (NKI-AVL), Amsterdam, The Netherlands.

Förderung

  • RSNA
  • Congressionally Directed Medical Research Programs
  • National Institute of Biomedical Imaging and Bioengineering
  • National Cancer Institute
  • NIH
  • American College of Radiation Oncology
  • Moores Cancer Center, UC San Diego Health
  • DOD

Zitieren

APA

Zhong, A. Y., Lui, A. J., Kuznetsova, S., Kallis, K., Conlin, C., Do, D. D., Domingo, M. R., Manger, R., Hua, P., Karunamuni, R., Kuperman, J., Dale, A. M., Rakow-Penner, R., Hahn, M. E., van der Heide, U. A., Ray, X., & Seibert, T. M. (2024). Clinical Impact of Contouring Variability for Prostate Cancer Tumor Boost. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2024.06.007

Vancouver

Zhong AY, Lui AJ, Kuznetsova S, Kallis K, Conlin C, Do DD, et al. Clinical Impact of Contouring Variability for Prostate Cancer Tumor Boost. International Journal of Radiation Oncology*Biology*Physics. 2024. doi:10.1016/j.ijrobp.2024.06.007

BibTeX
@article{Zhong2024,
  author = {Zhong, Allison Y and Lui, Asona J and Kuznetsova, Svetlana and Kallis, Karoline and Conlin, Christopher and Do, Deondre D and Domingo, Mariluz Rojo and Manger, Ryan and Hua, Patricia and Karunamuni, Roshan and Kuperman, Joshua and Dale, Anders M and Rakow-Penner, Rebecca and Hahn, Michael E and van der Heide, Uulke A and Ray, Xenia and Seibert, Tyler M},
  title = {Clinical Impact of Contouring Variability for Prostate Cancer Tumor Boost},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2024},
  doi = {10.1016/j.ijrobp.2024.06.007}
}
Kostenlos starten →